MoneyWorks4Me

Venus Remedies informs about press release

01 Jun 2023 Evaluate

Venus Remedies has informed that it enclosed press release being issued by the Company today titled ‘Venus Remedies consolidates its position in oncology space with Saudi marketing approval for Docetaxel’.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..